Rexahn Pharmaceuticals, Inc. (REXN)

[decouverte d Elbe]

Benaim Ely

REXAHN PHARMACEUTICALS, INC.
15245 SHADY GROVE ROAD, SUITE 455
ROCKVILLE MD 20850

REXAHN PHARMACEUTICALS, INC. [ RNN ] 5. Relationship of Reporting Person(s) to Issuer
Director 10% Owner
Chief Medical Officer
02/02/2015
X Form filed by One Reporting Person


Options vest and become exercisable based upon the following schedule: 300,000 on February 2, 2016, and 25,000 on the first business day of each month beginning March 2016 and ending February 2019.